Point-of-Care Testing for Cardiac Markers in Acute Coronary Syndromes and Heart Failure

Clinics in Laboratory Medicine

Volumn 29, Issue 3, 2009, Pages 561-571

  Lewandrowski, Kent ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Acute coronary syndrome; B type natriuretic peptide; Heart failure; Point of care; Troponin

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE MB; MYOGLOBIN; TROPONIN I; TROPONIN T;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANALYTICAL ERROR; BLOOD ANALYSIS; CONGESTIVE HEART FAILURE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DYSPNEA; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HOSPITAL ADMISSION; HUMAN; LABORATORY DIAGNOSIS; LENGTH OF STAY; NORMAL VALUE; POINT OF CARE TESTING; PRIORITY JOURNAL; PROGNOSIS; Q WAVE; REVIEW; SENSITIVITY AND SPECIFICITY; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; THORAX PAIN;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; CREATINE KINASE; CREATINE KINASE, MB FORM; DIAGNOSIS, DIFFERENTIAL; HEART FAILURE; HUMANS; IMMUNOASSAY; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; POINT-OF-CARE SYSTEMS; TROPONIN;

EID: 70350029506     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2009.06.007     Document Type: Review

References (29)

1. Collinson P. Testing for cardiac markers at the point of care. Clin Lab Med 21 (2001) 351-362
2. Wu A. Point of care testing for cardiac markers: has the time come. Point of Care 1 (2002) 39-61
3. Blomkalns A. Point of care testing for ACS in the emergency department. Emergency Medicine Cardiac Research and Education Group monograph. In: Blomkalns A., and Gibler B. (Eds). American College of Emergency Physicians Scientific Assembly Satellite Symposium (2005), College of American Pathologists, Chicago IL. http://www.emcreg.org Available at: www.emcreg.org
4. Ming S., Padma K., Morissey R., et al. Ninety minute accelerated critical pathway for chest pain evaluation. Am J Cardiol 88 (2001) 611-616
5. Dadkhah S., Sharain K., Sharain R., et al. The value of bedside cardiac multimarker assay in rapid and accurate diagnosis of acute coronary syndromes. Crit Pathw Cardiol 6 (2007) 76-84
6. Alpert J., Antman E., Apple F., et al. Myocardial infarction redefined. A consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
7. Puleo P., Meyer D., Wathen C., et al. Use of a rapid assay of subforms of creatinine kinase MB to diagnose or rule out acute myocardial infarction. N Engl J Med 331 (1994) 561-566
8. Hamm C. Cardiac biomarkers for rapid evaluation of chest pain. Circulation 104 (2001) 1454-1459
9. Lee-Lewandrowski E., Corboy D., Lewandrowski K., et al. Implementation of a point of care satellite laboratory in the emergency department of an academic medical center. Impact on test turnaround time and patient emergency department length of stay. Arch Pathol Lab Med 127 (2003) 456-460
10. McCord J., Nowak R., McCullough P., et al. Ninety minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I (CHECKMATE) study. Circulation 103 (2001) 1832-1837
11. Di Serio F., Antonelli G., Trerotoli P., et al. Appropriateness of point of care testing (POCT) in an emergency department. Clin Chim Acta 333 (2003) 185-189
12. Apple F., Chung A., Kogut M., et al. Decreased patient charges following implementation of point of care cardiac troponin monitoring in acute coronary syndrome patients in a community hospital cardiology unit. Clin Chim Acta 370 (2006) 191-195
13. Ryan R., Linsell C., Hollander J., et al. A multicenter randomized controlled trial comparing central laboratory and point of care cardiac marker testing strategies: the disposition impacted by serial point of care markers in acute coronary syndromes (DISPO-ACS) trial. Ann Emerg Med (2008) [epublication ahead of print]
14. Storrow A. A systematic review of emergency department point-of-care cardiac markers and ED efficiency measures. Point of Care, in press.
15. Apple F., Jesse R., Newby K., et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem 53 (2007) 547-551
16. Lee-Lewandrowski E., Benzer T., Corboy D., et al. Cardiac marker testing as part of an emergency department point-of-care satellite laboratory in a large academic medical center. Practical issues concerning implementation. Point of Care 1 (2002) 145-154
17. Casals G., Filella X., Auge J., et al. Impact of ultrasensitive cardiac troponin I dynamic changes in the new universal definition of myocardial infarction. Am J Clin Pathol 130 (2008) 964-998
18. Lusky K. Troponin: new tool in an old friend. CAP Today 23 (2009) 1-17
19. Morrow D., deLemos J., Sabatine M., et al. The search for a biomarker of ischemia. Clin Chem 49 (2003) 537-539 [editorial]
20. Apple F., Wu A., Mair J., et al. Future biomarkers of ischemia and risk stratification in acute coronary syndrome. Clin Chem 51 (2005) 810-824
21. Maisel A., Bhalla V., and Braunwald E. Cardiac biomarkers: a contemporary status report. Nat Clin Pract Cardiovasc Med 3 (2006) 24-34
22. deFilippi C. Natriuretic peptides for diagnosing heart failure and beyond: what we know in 2007. Medscape continuing medical education 2007 (May). Available at:. www.medscape.com Accessed May 24, 2007
23. Januzzi J., Camargo C., Anwaruddin S., et al. The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95 (2005) 948-954
24. Mueller C., Scholer A., laule K., et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350 (2004) 647-654
25. Clerico A., Fontana M., Passino C., et al. Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure. Clin Chem 53 (2007) 813-822
26. Green S., Redmond K., Januzzi J., et al. The impact of amino-terminal pro-brain natriuretic peptide testing on hospital length of stay and morbidity in patients with acute heart failure. Arch Pathol Lab Med 131 (2007) 473-476
27. Blick K. Economics of point-of-care testing for cardiac markers and B-natriuretic peptide (BNP). Point of Care 4 (2005) 11-14
28. Breidthardt T., Laule K., Strohmeyer A., et al. Medical and economic long term effects of B-type natriuretic peptide testing in patients with acute dyspnea. Clin Chem 53 (2007) 1415-1422
29. Jourdain P., Jondeau G., Funck F., et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 49 (2007) 1733-1739